Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against N. caninum infection was evaluated in vitro and in vivo. Two major immunodominant surface antigens (NcSAG1 and NcSRS2) and two dense granule proteins (NcDG1 and NcDG2) of N. caninum tachyzoites were expressed in E. coli, respectively. An in vitro neutralization assay using polyclonal antisera raised against each recombinant antigen showed inhibitory effects on the invasion of N. caninum tachyzoites into host cells. Separate groups of gerbils were immunized with the purified recombinant proteins singly or in combinations and animals were then challenged with N. caninum infection. Following these experimental challenges, the protective efficacy of each vaccination was determined by assessing animal survival rate. All experimental groups showed protective effects of different degrees against experimental infection. The highest protection efficacy was observed for combined vaccination with NcSRS2 and NcDG1. Our results indicate that combined vaccination with the N. caninum recombinant antigens, NcSRS2 and NcDG1, induces the highest protective effect against N. caninum infection in vitro and in vivo, and suggest that they should be considered as a desirable combination for N. caninum vaccine development.
참고문헌 (14)
- "Immunogenicity of a killed Neospora caninum tachyzoite preparation formulated with different adjuvants", 29, pp.1613~1625 (1999)
- "Effect of polyclonal antisera developed against dense granule-associated Neospora caninum proteins on cell invasion and development in vitro by N", 119, pp.441~445 (1999)
- "Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines", 126, pp.303~312 (2003)
- "Humoral immune responses and safety of experimental formulations of inactivated Neospora vaccines", 86, pp.851~853 (2000)
- "A review of Neospora caninum and neosporosis", 67, pp.1~59 (1996)
- "Review of Neospora caninum and neosporosis in animals", 41, pp.1~16 (2003)
- "Identification of a major surface protein on Neospora caninum tachyzoites", 82, pp.497~504 (1996)
- "The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii", 66, pp.5322~5328 (1998)
- "Immune responses to Neospora caninum and prospects for vaccination", 18, pp.497~504 (2002)
- "Prevention of vertical transfer of Neospora caninum in BALB", c mice by vaccination, 1999, pp.85, 1072~1075
- "Comparison of intracerebral parasite load and systemic cytokines in mouse strains infected with Neospora caninum", 84, pp.316~320 (1998)
- "p values for pathogens statistical inference from infectious-disease data", 2, pp.219~230 (2002)
- "Prevention of vertical transmission of Neospora caninum in BALB", c mice by recombinant vaccinia virus carrying NcSRS2 gene, 2001, pp.19, 1710~1716
- "Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions", 123, pp.149~159 (2004)
